Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
University of Michigan–Ann Arbor · Michigan Center for Translational Pathology · +1 more institution
Abstract
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer. Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo model systems. Transgenic mice expressing the ERG gene fusion product under androgen-regulation develop mouse prostatic intraepithelial neoplasia (PIN), a precursor lesion of prostate cancer. Introduction of the ERG gene fusion product into primary or immortalized benign prostate epithelial cells induced an invasion-associated transcriptional program but did not increase cellular proliferation or anchorage-independent growth. These results suggest that TMPRSS2-ERG may not be sufficient for transformation in the absence of secondary molecular…
Citation impact
- FWCI
- 36.39
- Percentile
- 100%
- References
- 52
Authors
12- SAScott A. Tomlins
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- BLBharathi Laxman
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- SVSooryanarayana Varambally
Michigan Center for Translational Pathology, University of Michigan–Ann Arbor
- XCXuhong Cao
University of Michigan–Ann Arbor, Michigan Center for Translational Pathology
- JYJindan Yu
Michigan Center for Translational Pathology, University of Michigan–Ann Arbor
Topics & keywords
- TMPRSS2
- Prostate cancer
- Fusion gene
- Erg
- Prostate
- Cancer research
- Biology
- Gene knockdown
- Good health and well-being